PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
about
Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countriesPerformance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter studyMalaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in TanzaniaUse of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in MaliHigh performance of histidine-rich protein 2 based rapid diagnostic tests in French Guiana are explained by the absence of pfhrp2 gene deletion in P. falciparum.Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests.Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance.A Field-Tailored Reverse Transcription Loop-Mediated Isothermal Assay for High Sensitivity Detection of Plasmodium falciparum InfectionsExploring health practitioners' acceptability of a prospective semi-quantitative pfHRP2 device to define severe malaria in the Democratic Republic of Congo.Malaria burden and anti-malarial drug efficacy in Owando, northern CongoUse of rapid diagnostic tests in malaria school surveys in Kenya: does their under-performance matter for planning malaria control?Application of loop-mediated isothermal amplification for malaria diagnosis during a follow-up study in São Tomé.SD Bioline malaria antigen Pf (HRP-2/pLHD) for assessing efficacy of artemisinin combination therapy against Plasmodium falciparum in pediatric patients in the Democratic Republic of the Congo.Field evaluation of HRP2 and pan pLDH-based immunochromatographic assay in therapeutic monitoring of uncomplicated falciparum malaria in Myanmar.Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings.Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy.Evaluation of Paracheck-Pf(TM) rapid malaria diagnostic test for the diagnosis of malaria among HIV-positive patients in Ibadan, south-western Nigeria.Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies.Case Report: A Case of Plasmodium falciparum hrp2 and hrp3 Gene Mutation in Bangladesh.Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation.Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy.Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.Discovery of Antimalarial Drugs from Streptomycetes Metabolites Using a Metabolomic Approach.How long do rapid diagnostic tests remain positive after anti-malarial treatment?
P2860
Q24187092-A63781F0-E1B2-44A0-B1DB-880FF4986E16Q31140691-514B6B25-0985-46F8-A5F9-4D0DBD4E2609Q33959247-FBA2E10A-E1F1-4585-BADB-23AD73761937Q34083032-9D2AF282-BC19-4EA7-A410-CFC136B3FAA6Q35004949-BA86A52F-C404-47AD-AF48-3C235E55B84BQ35917807-4BA15BA1-A71F-4FC5-B135-EDF728C78FCDQ35984759-6C104F80-47BF-4DB9-AFB4-EBBA6B608E7DQ36185543-B6D69E02-AA9F-4F40-A3DF-BDA561009DE2Q36376572-FF3BDA5A-E261-47CE-A401-F77279F19575Q36443044-4BE12E0A-4374-409D-B99C-D79FB339C75BQ36450089-7AB2BF8C-85A2-45BA-9191-88118ECAE18DQ36483337-714D7C3D-70C1-4312-9E42-49CCCA8DDD94Q36624266-920ACC78-56AB-4103-BBCE-3F154D91B951Q36794306-34A67678-E427-498A-B313-16A7D3CAB17EQ37310976-C3D2A9F9-C80A-4ED5-BD23-5606AADED5B2Q37362024-23F2474A-6678-41DA-8F44-C31519B50106Q37726524-FB11E1AB-AD4A-4E7E-8FE5-BB992D73320EQ38935685-975D2FB4-028F-4023-8028-81FB8EEE6CF7Q40088270-288EE904-0C45-47B9-99B0-906B2FE769BEQ42257508-E12E61C2-08F5-45AA-BDBA-411135D8E3C9Q43929546-1D7222AF-334A-45A5-99C5-27BB9E05488AQ44157364-97327E13-8980-4B44-92AA-58FB1EAAEB1CQ47102373-0FC41C6C-2413-4067-A1F3-CFE62A57EDDCQ55265346-EB96CD21-75B8-45B2-9159-22E9A2875380
P2860
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PfHRP2 and PfLDH antigen detec ...... omplicated falciparum malaria.
@en
PfHRP2 and PfLDH antigen detec ...... inin-based combination therapy
@nl
type
label
PfHRP2 and PfLDH antigen detec ...... omplicated falciparum malaria.
@en
PfHRP2 and PfLDH antigen detec ...... inin-based combination therapy
@nl
prefLabel
PfHRP2 and PfLDH antigen detec ...... omplicated falciparum malaria.
@en
PfHRP2 and PfLDH antigen detec ...... inin-based combination therapy
@nl
P2860
P50
P921
P356
P1433
P1476
PfHRP2 and PfLDH antigen detec ...... omplicated falciparum malaria.
@en
P2093
Jean-François Faucher
P2860
P2888
P356
10.1186/1475-2875-8-211
P577
2009-09-07T00:00:00Z
P5875
P6179
1042991895